Table A3.
Health characteristics of all adults aged 18 and older, by drug use category – United States, 2015–2018.
| Characteristic | Weighted % (95 % CI) | ||
|---|---|---|---|
| Opioid use (N = 1534) | Methamphetamine use (N = 1089) | Opioid and Methamphetamine use (N = 398) | |
| Fair/poor health | 29.4 (25.5–33.3) | 26.3 (22.3–30.2) | 32.6 (25.4–39.8) |
| Any infectious disease | 11.9 (9.8–14.0) | 17.5 (13.4–21.7)c | 22.9 (17.4–28.4)a |
| STI (past year) | 6.3 (5.0–7.7) | 8.9 (6.5–11.4)c | 9.6 (5.8–13.4)c |
| HIV/AIDS | 0.5 (0.0–1.0) | 4.1 (1.7–6.5)b | 1.1 (−0.5–2.6)c |
| Hepatitis B or C | 6.4 (4.6–8.1) | 8.5 (5.4–11.6) | 13.3 (9.5–17.3)a,d |
| Any respiratory disease | 11.8 (9.7–13.8) | 16.5 (13.6–19.4)b | 17.9 (12.1–23.7)c |
| Asthma | 7.3 (5.8–8.7) | 8.1 (6.5–9.7) | 7.3 (3.8–10.9) |
| COPD | 6.5 (5.0–8.0) | 10.3 (7.8–12.9)b | 12.8 (7.5–18.1)b |
| Any cardiovascular disease | 20.6 (16.9–24.2) | 19.4 (15.5–23.4) | 27.0 (20.3–33.8)d |
| Heart condition | 8.6 (6.2–11.0) | 9.3 (6.6–12.1) | 12.7 (6.3–19.2) |
| High blood pressure | 15.2 (12.0–18.4) | 14.2 (10.4–18.0) | 22.1 (16.0–28.2)c,d |
| Diabetes | 8.5 (6.5–10.6) | 8.2 (5.2–11.1) | 5.9 (1.7–10.2) |
| Kidney disease | 1.2 (0.5–1.9) | 2.5 (0.8–4.2) | 0.6 (0.0–1.1)d |
| Cancer | 2.5 (1.6–3.4) | 4.3 (1.7–6.8) | 4.2 (1.5–6.9) |
| Chronic Conditions per 100 individuals | 56.6 (49.7–63.5) | 70.1 (59.9–80.3)c | 81.0 (64.6–97.3)b |
| Any disability | 38.6 (34.9–42.4) | 39.8 (35.5–44.1) | 42.1 (35.5–48.7) |
| Severe mental illness | 20.3 (17.0–23.5) | 22.5 (17.6–27.5) | 31.6 (24.7–38.4)b |
| Uninsured | 20.6 (17.9–23.3) | 22.6 (19.3–25.9) | 24.9 (18.0–31.9) |
All estimates are adjusted for age, sex, income, education, rural vs. urban residence, race/ethnicity, and housing instability in the past year.
Opioid use is defined as any past year heroin use or misusing prescription pain relievers 4 or more times in the past month. Methamphetamine use is defined as any past year methamphetamine use.
a
P≤.0.001 compared to “Opioid use”.
b
P≤.0.01 compared to “Opioid use”.
c
P≤.0.05 compared to “Opioid use”.
d
P≤.0.05 compared to “Methamphetamine use”.